QuidelOrtho Corp 8-K

What Happened
QuidelOrtho Corporation filed an 8-K (Feb 5, 2026) reporting that director Matthew W. Strobeck notified the Board on January 30, 2026 that he will not stand for re-election at the Company’s 2026 annual stockholders meeting. Dr. Strobeck will remain a director until the annual meeting, at which time the Board will be reduced from eleven to ten members.

Key Details

• Director: Matthew W. Strobeck provided notice on January 30, 2026 and will serve until the 2026 annual meeting.
• Board size: Will be reduced from 11 to 10 directors effective at the annual meeting.
• Tenure and reason: Dr. Strobeck served eight years on the Board and cited other professional commitments; his departure is not due to any disagreement with the Company, Board, or management.
• Filing: Change reported in a Form 8-K filed February 5, 2026.

Why It Matters
This is a governance update rather than an operational or financial event. The reduction of one board seat and Strobeck’s planned departure could affect board composition and committee assignments, so investors should watch upcoming proxy materials and the annual meeting for information on any new nominees or committee changes. The filing explicitly states the departure was voluntary and not the result of any dispute, suggesting no reported governance conflict.